Solv-Ex corp. chairman keeps the faith – The Financial Post
Solv-Ex corp. chairman keeps the faith – The Financial Post
Articles by Asensio.com
Avant! reports dismal third quarter results.
Yesterday, Avant! (OTC Symbol: AVNT) (Price: $26.75) announced what it called “extremely gratifying” third quarter results. The results barely exceeded analyst’s unrevised low expectations before a $41.2 million write-off. Analysts have failed to increase their […]
Avant!’s Compass dealings exposed.
During the third quarter Avant! Corporation (NASDAQ Trading Symbol: AVNT) (Price: $26.75) agreed to acquire two companies for a stated transaction value of approximately $206 million payable in cash and stock. These are Avant!’s only […]
Tortured Solv-Ex tale not over – Business West
Tortured Solv-Ex tale not over – Business West
Solv-Ex has no valuable asset to sell and no bids of any kind.
Reports continue to circulate about the value of the “Geopetrol letter” to Solv-Ex shareholders. The “Geopetrol letter” does not offer to buy any asset owned by Solv-Ex or any of its subsidiaries at any price. […]
Solv-Ex Geopetrol farce exposed.
Asensio & Company, Inc. has today notified Chief Justice W.K. Moore of the Court of Queen’s Bench of Alberta, who is the residing judge in Solv-Ex Corporation’s (“Solv-Ex”) Canadian Creditors Arrangement proceedings, of the press […]
ErgoBilt fails to dispute disclosure failures.
ErgoBilt has issued a total of five (5) press releases since Asensio & Company, Inc. published its strong sell recommendation on its shares. Four (4) of these press releases contained comments about Asensio’s reports. We […]
Solv-Ex shareholder value eliminated.
Reports that an offer from Geopetrol “would be enough to pay” all of Solv-Ex Corporation’s (OTC Symbol: SOLVQ) (Price: N/A) debts are completely false and untrue. Geopetrol’s highly conditional offer to buy Solv-Ex’s remaining assets […]
ErgoBilt fails to disclose adverse court decision.
On August 22, 1997 United States District Judge Lynn N. Hughes dismissed BodyBilt, Inc.’s (“BodyBilt”) lawsuit against Dr. Jerome J. Congleton (“Dr. Congleton”). Dr. Congleton patented certain ergonomic designs (“Patent”) that are used in BodyBilt’s […]
ErgoBilt fraudulently promotes obsolete technology.
ErgoBilt, Inc. (“ErgoBilt”) has announced the acquisition of Computer Translation Systems & Support, Inc.’s (“CTSS”) “proprietary assets” and the employment of its alleged principals Larry West and Jerold P. Lefler as President and Executive Vice […]
Asensio & Company issues Strong Sell on ErgoBilt, Inc.
ErgoBilt, Inc. (OTC Stock Trading Symbol: ERGB) (Price: $14.00) has been promoting its Fon’iks Writer as a new and better technology for the court reporting and Rapid Text Entry markets. Just yesterday the Company issued […]
Biovail’s alleged Cardizem CD will not reverse sales and earnings decline.
Biovail Corp. (Symbol: BVF) (Price: 28.625) International has announced Hoechst Marion Roussel (“HMR”) did not challenge its ANDA filing for a generic Cardizem CD product within the required 45-day time limit under Waxman Hatch. This […]
Investment firm issues “strong sell” for Avant! – EE Times
Investment firm issues “strong sell” for Avant! – EE Times
Avant! exposed to enjoining order on theft of database alone.
On August 12, 1997 Cadence Design Systems, Inc. (“Cadence”) requested that the U.S. Court of Appeals for the Ninth Circuit reverse those parts of U.S. District Judge Ronald M. Whyte’s March 1997 Order that failed […]
Avant! reported to be losing market share.
Avant! Corporation (“Avant!”) (OTC Symbol: AVNT) (Price: $32.00) is claiming that its recent sales success has resulted from its technical superiority and consistently better performance over Cadence Design Systems, Inc. (“Cadence”). We found no evidence […]
Sterling Vision’s false takeover reports allow insiders to sell at inflated prices.
Investors have bid-up Sterling Vision’s stock based on completely false yet widely-published reports of large “smart-money” buying based on an anticipated “buyout” and a “share buyback” plan. Neither of these events is remotely possible and […]
Concentric: A Networker with Navigation Trouble – TheStreet.Com
Concentric: A Networker with Navigation Trouble – TheStreet.Com
Ever-Volatile, Trading in Diana raises new Questions – Dow Jones
Ever-Volatile, Trading in Diana raises new Questions – Dow Jones
Diana Corp: Co boasts of Pvt Placement, Dow Jones Critics Attack It – Dow Jones
Diana Corp: Co boasts of Pvt Placement, Dow Jones Critics Attack It – Dow Jones
Diana filing reveals negative impact of recent financings.
Diana’s misleading announcements concerning its recent financings and transactions, along with its failure to file required financial disclosures, have caused investors to grossly overestimate the Company’s value. The facts detailed below show that Diana obtained […]
Solv-Ex Corp.’s extraction of bitumen from oil sands – Oilweek
Solv-Ex Corp.’s extraction of bitumen from oil sands – Oilweek
Strong Sell Recommendation
Avant! cancels recusal hearing. Avant! (OTC Symbol: AVNT) (Price: $29.875) cancelled all hearings scheduled for this week to argue its much-heralded motion requesting the dismissal of District Attorney Julius L. Finkelstein. No new hearing date […]
Short-Seller Asensio Slaps “Strong Sell” On Avant! – Dow Jones
Short-Seller Asensio Slaps “Strong Sell” On Avant! – Dow Jones
Telecommunications Services & Equipment – The Wall Street Transcript
Telecommunications Services & Equipment – The Wall Street Transcript
Diana will realize no gain from Concentric’s offering or lawsuit.
Investors have sharply bid up Diana’s shares anticipating that a possible $29.5 million gain from Concentric Network Corporation’s (“Concentric”) planned initial public offering (“IPO”) may alleviate the Company’s “going concern” crisis. However, Diana has failed […]
Solv-Ex declared insolvent – The Financial Post
Solv-Ex declared insolvent – The Financial Post
Solv-Ex ducks creditors – The Edmonton Sun
Solv-Ex ducks creditors – The Edmonton Sun
Solv-Ex possesses no titanium dioxide product.
Solv-Ex claims to have developed a new product for the paper industry called TiO2S, which is supposed to be a substitute for titanium dioxide. Solv-Ex also claims to have an “alliance” with Raisio Chemicals Oy […]
Solv-Ex technical employee provides definitive proof of fraud.
Robert Gill, Solv-Ex’s laboratory coordinator at its Fort McMurray plant, has provided a written statement and highly detailed account of Solv-Ex’s attempt to produce bitumen. The account is completely documented and has been provided to […]
Solv-Ex attempts new Reg S offering. Conversion may cause shares to exceed amount authorized.
On June 18, 1997 Solv-Ex entered into an agreement with Greystone Capital Ltd. to attempt the sale of a new $11 million convertible Reg S offering. Solv-Ex already has a $10 million convertible Reg S […]